Evidence map›Paper›PMID 39967018›Full record

ArticleBriefings in bioinformatics2024

Incremental modelling and analysis of biological systems with fuzzy hybrid Petri nets.

George Assaf, Fei Liu, Monika Heiner

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

George AssafDepartment of Computer Science, Brandenburg University of Technology Cottbus-Senftenberg, 03013 Cottbus, Germany.ORCID 0000-0002-8878-5871
Fei LiuSchool of Software Engineering, South China University of Technology, No. 381 Wushan Road, Guangzhou 510006, P.R. China.ORCID 0000-0001-9415-0496
Monika HeinerDepartment of Computer Science, Brandenburg University of Technology Cottbus-Senftenberg, 03013 Cottbus, Germany.

Funding

Guangdong Basic and Applied Basic Research Foundation 2024A1515010900National Natural Science Foundation of China 62273153
6 · The paper itself

Abstract

Modelling biological systems depends on the availability of data and components of the system at hand. As our understanding of these systems evolves, the ability to gradually refine models by adding new components of different formalisms covering stochastic, discrete, deterministic, and uncertainty without starting from scratch becomes essential. However, there remains a significant gap in the availability of methodologies and tool support for incrementally modelling and analysing complex biological systems in a flexible and intuitive manner. In this paper, we employ fuzzy hybrid Petri nets as a powerful expressive tool for presenting an incremental modelling and analysis protocol of biological systems. We demonstrate the utility of our protocol through a case study on cholesterol and lipoprotein metabolism and hypercholesterolemia therapy. Our model not only captures the underlying biochemical processes, but also quantitatively analyses how cholesterol levels are regulated, offering insights into potential therapeutic strategies for diseases associated with elevated cholesterol levels. The results confirm the validity and flexibility of our approach in representing complex biological processes and therapeutic interventions.

Indexed as

Fuzzy LogicModels, BiologicalAlgorithmsCholesterolHumansHypercholesterolemiaLipoproteinsCholesterolLipoproteinsand parametric uncertainty modellingcholesterol metabolismdeterministicdiscretefuzzy hybrid Petri netsincremental modellingstochastic

Identifiers

PMID39967018
PMCPMC11833693

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.